← All comparisons
Head-to-head · FAERS comparison

Methotrexate vs Hydroxychloroquine: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

MethotrexateHydroxychloroquine
Drug class––
Brand names––
FAERS reports483,09790,536
Serious73%75%
Death outcome37,6406,265
Boxed warningYes WARNING: EMBRYO-FETAL TOXICITY, HYPERSENSITIVITY REACTIONS, BENZYL ALCOHOL TOXICITY, and OTHER SERIOUS ADVERSE REACTIONS • Methotrexate Injection can cause embrNo

Signals both drugs share

ReactionMethotrexateHydroxychloroquineLabel screen (A / B)
Pericarditis6,863 · PRR 30.05,077 · PRR 101.6Labeled adverse reaction / Not in label — unassessed
Duodenal ulcer perforation5,067 · PRR 97.33,870 · PRR 260.7Labeled (related wording) / Not in label — unassessed
Muscle injury4,306 · PRR 47.53,019 · PRR 135.1Not in label — unassessed / Labeled (related wording)
Sleep disorder due to general medical condition, insomnia type3,191 · PRR 42.22,401 · PRR 138.1Not in label — unassessed / Labeled (related wording)
Bone erosion2,084 · PRR 61.71,129 · PRR 108.4Labeled (related wording) / Not in label — unassessed
Synovitis13,569 · PRR 133.88,328 · PRR 199.7Not in label — unassessed / Not in label — unassessed
Pemphigus9,382 · PRR 135.97,446 · PRR 351.1Not in label — unassessed / Not in label — unassessed
Hand deformity8,885 · PRR 92.36,673 · PRR 243.2Not in label — unassessed / Not in label — unassessed
Helicobacter infection5,277 · PRR 46.13,923 · PRR 145.4Not in label — unassessed / Not in label — unassessed
Folliculitis5,035 · PRR 40.83,344 · PRR 111.0Not in label — unassessed / Not in label — unassessed
Rheumatic fever3,282 · PRR 133.32,381 · PRR 280.5Likely indication confounding / Likely indication confounding
Facet joint syndrome1,964 · PRR 71.61,242 · PRR 151.1Not in label — unassessed / Not in label — unassessed
Deep vein thrombosis postoperative1,372 · PRR 101.81,022 · PRR 254.3Not in label — unassessed / Not in label — unassessed
Dislocation of vertebra1,211 · PRR 51.4854 · PRR 144.7Not in label — unassessed / Not in label — unassessed
Adjustment disorder with depressed mood1,109 · PRR 52.7787 · PRR 148.8Not in label — unassessed / Not in label — unassessed
Lupus vulgaris867 · PRR 117.7626 · PRR 259.4Not in label — unassessed / Not in label — unassessed
Retinitis790 · PRR 38.5537 · PRR 109.9Not in label — unassessed / Not in label — unassessed
Granuloma skin539 · PRR 80.8364 · PRR 182.4Not in label — unassessed / Not in label — unassessed

Labeled signals distinctive to Methotrexate

Labeled signals distinctive to Hydroxychloroquine

  • Glossodynia — n=6,867, PRR 102.8 Labeled (related wording)

Common questions

Which has more reported side effects, Methotrexate or Hydroxychloroquine?

Methotrexate has 483,097 FAERS reports and Hydroxychloroquine 90,536. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (73% vs 75%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Methotrexate and Hydroxychloroquine share?

Both drugs carry disproportionality signals for pericarditis, duodenal ulcer perforation, muscle injury, sleep disorder due to general medical condition, insomnia type, bone erosion. Shared signals often reflect a shared drug class or the condition both are used for.

Is Methotrexate or Hydroxychloroquine safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.